HEIDELBERG, Germany, Nov 17 (Bernama-PRNewswire) — European Wellness Academy (EWA), a member of European Wellness Biomedical Group (EWBG), recently signed its second research contract involving General In Vitro/In Vivo Safety and Toxicity Tests for Preclinical Studies of Regenerative Peptides with Heidelberg University.
The research contract signed is a continuation of the previous research on the efficacy of the Group’s cutting-edge biotherapeutics including precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelles (MO), Nano Organo Peptides (NOP) and exosomes.
- Chinese Firm To Fund 1-Billion-USD Major Chemical Complex In Egypt
- Egypt Repatriated 17 Ancient Artefacts From Australia
- Update: South Africa slams Trump’s G20 ban as punitive
- UN extends Libya arms embargo ship inspections
- Cuba and BRICS strengthen alliance at FIHAV 2025
- U.S. Missile Strikes In Caribbean Violate Human Rights, Says Venezuelan Attorney General
- Iran Condemns Australia’s Designation Of IRGC As “State Sponsor Of Terrorism”
- 106 Israeli Air Strikes Recorded In Southern Lebanon Over Past Year: UN
- Syria Faces Rising Security Tensions Amid Sectarian Unrest, Protests
- Weapon Cache Seized In Afghanistan’s Uruzgan Province